SAMUEL TWEDT: Open Payments
NPI 1518451137 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 21 payments from 6 companies in 2025. Trend: 2023 $1,084 · 2024 $653 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Lilly USA, LLC | 5 | $112 |
| ABBVIE INC. | 4 | $106 |
| Novo Nordisk Inc | 4 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Amgen Inc. | 2 | $36 |
Products named: BREZTRI, UBRELVY, JARDIANCE, Ozempic, CAPLYTA, FARXIGA, MOUNJARO, EVENITY.
Industry payments across MS — which companies pay providers there.
